Literatura académica sobre el tema "Cyclic guanosine 3',5'-monophosphate"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Cyclic guanosine 3',5'-monophosphate".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Cyclic guanosine 3',5'-monophosphate"
Srivastava, Uma S., Manohar Lal Thakur y C. Spach. "Cyclic 3′, 5′-adenosine monophosphate and cyclic 3′, 5′-guanosine monophosphate metabolism in malnutrition". Nutrition Research 6, n.º 5 (mayo de 1986): 589–99. http://dx.doi.org/10.1016/s0271-5317(86)80113-0.
Texto completoBoadu, Emmanuel, Svanhild Vaskinn, Elisabeth Sundkvist, Ragnhild Jaeger y Georg Sager. "Inhibition by guanosine cyclic monophosphate (cGMP) analogues of uptake of [3H]3′,5′-cGMP without stimulation of ATPase activity in human erythrocyte inside-out vesicles11Abbreviations: 3′,5′-cGMP, guanosine 3′,5′-cyclic monophosphate; 2′,3′-cGMP, guanosine 2′,3′-cyclic monophosphate; N-mb-cGMP, N2-monobutyryl guanosine 3′,5′-cyclic monophosphate; O-mb-cGMP, 2′-O-monobutyryl guanosine 3′,5′-cyclic monophosphate; Db-cGMP, N2,2′-O-dibutyryl guanosine 3′,5′-cyclic monophosphate; Br-cGMP, 8′-bromo guanosine 3′,5′-cyclic monophosphate; Rp-cGMPS, Rp-monophosphorothioate guanosine 3′,5′-cyclic monophosphate; Sp-cGMPS, Sp-monophosphorothioate guanosine 3′,5′-cyclic monophosphate; 3′,5′-cAMP, Adenosine 3′,5′-cyclic monophosphate; and MRP, multidrug resistance protein." Biochemical Pharmacology 62, n.º 4 (agosto de 2001): 425–29. http://dx.doi.org/10.1016/s0006-2952(01)00682-7.
Texto completoPradelles, Philippe, Jacques Grassi, Danielle Chabardes y Nicole Guiso. "Enzyme immunoassays of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate using acetylcholinesterase". Analytical Chemistry 61, n.º 5 (marzo de 1989): 447–53. http://dx.doi.org/10.1021/ac00180a014.
Texto completoBeste, Kerstin Y. y Roland Seifert. "cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: Development of a hypothesis based on studies with soluble guanylyl cyclase α1β1". Biological Chemistry 394, n.º 2 (1 de febrero de 2013): 261–70. http://dx.doi.org/10.1515/hsz-2012-0282.
Texto completoMeskini, N., O. MacOvschi, A. F. Prigent, G. Nemoz, P. Chapuy y M. Lagarde. "Decreased Cyclic Nucleotide Phosphodiesterase Activity in Human Peripheral Blood Mononuclear Cells from Elderly Women". Clinical Science 79, n.º 5 (1 de noviembre de 1990): 467–70. http://dx.doi.org/10.1042/cs0790467.
Texto completoMattana, J. y P. C. Singhal. "Effects of atrial natriuretic peptide and cGMP on uptake of IgG complexes by macrophages". American Journal of Physiology-Cell Physiology 265, n.º 1 (1 de julio de 1993): C92—C98. http://dx.doi.org/10.1152/ajpcell.1993.265.1.c92.
Texto completoGéigel, LF y LL Leon. "Cyclic 3'-5' guanosine monophosphate-dependent activity in Leishmania amazonensis". Memórias do Instituto Oswaldo Cruz 98, n.º 4 (junio de 2003): 499–500. http://dx.doi.org/10.1590/s0074-02762003000400012.
Texto completoSanty, L. C. y G. Guidotti. "Reconstitution and characterization of two forms of cyclic nucleotide-gated channels from skeletal muscle". American Journal of Physiology-Endocrinology and Metabolism 271, n.º 6 (1 de diciembre de 1996): E1051—E1060. http://dx.doi.org/10.1152/ajpendo.1996.271.6.e1051.
Texto completoChen, Da-Chung, Shyng-Shiou F. Yuan, Her-Young Su, Shin-Chieh Lo, Shin-Sia Ren y Gwo-Jang Wu. "Urinary cyclic guanosine 3′,5′-monophosphate and cyclic adenosine 3′,5′-monophosphate changes in spontaneous and induced onset active labor". Acta Obstetricia et Gynecologica Scandinavica 84, n.º 11 (17 de octubre de 2005): 1081–86. http://dx.doi.org/10.1111/j.0001-6349.2005.00831.x.
Texto completoHorton, J. K., R. C. Martin, S. Kalinka, A. Cushing, J. P. Kitcher, M. J. O'Sullivan y P. M. Baxendale. "Enzyme immunoassays for the estimation of adenosine 3',5'cyclic monophosphate and guanosine 3',5'cyclic monophosphate in biological fluids". Journal of Pharmacological and Toxicological Methods 29, n.º 4 (agosto de 1993): 234. http://dx.doi.org/10.1016/1056-8719(93)90032-a.
Texto completoTesis sobre el tema "Cyclic guanosine 3',5'-monophosphate"
Sriraman, R. "Cyclic guanosine 3', 5' - cyclic monophosphate (cGMP) enhancement & its relationship to vascular function & insulin sensitivity". Thesis, Exeter and Plymouth Peninsula Medical School, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701082.
Texto completoLi, Ying 1972 Mar 31. "The effects of cyclic guanosine 3', 5'-monophosphate analog on protein accumulation in adult rat cardiomyocytes in vitro /". Thesis, McGill University, 2007. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=101863.
Texto completoHamad, Ahmed El-Sayed Mansour Abd El-Mohsen. "Guanosine 3': 5'-cyclic monophosphate regulation in cultured human airway smooth muscle cells and its role in proliferation". Thesis, University of Nottingham, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.298959.
Texto completoCardoso, Andrea Rodrigues. "Mapeamento global de interações proteicas nas vias de sinalização mediadas por c-di-GMP de Pseudomonas aeruginosa". Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/76/76132/tde-17052016-094656/.
Texto completoPersister bacteria are correlated to biofilm formation and have been a source of great medical concern due to its close association with the impairment of traditional treatment in combating chronic infections. On the other hand, using bacterial biofilms to create original biotechnological applications or even as a means of therapeutic treatment in medical settings constitutes a promising prospect. There is, therefore, a great interest in understanding the mechanisms that allow bacteria to leave the free-living planktonic lifestyle and associate in these highly complex cellular aggregates. Over the last decades, the second messenger c-di-GMP – and also the molecules involved in its synthesis (diguanylate ciclases) and degradation (phosphodiesterases) along with its receptors – has been established as a key element implicated in regulation of a series of cellular responses that determine biofilm formation or dispersion. Curiously, the proteins that play a part in the metabolism of this second messenger are frequently coded multiple times in single bacterial genomes. Taking this into account, recent studies indicate that, in order to control such a wide range of phenotypes, this system operates via high specificity of signaling – which means that the signal metabolized by a certain set of diguanylate ciclases and phosphodiesterases has specific cellular targets. Robust but yet isolated evidence indicate that a means by which a signal is segregated with its correlated phenotypic response is through direct protein-protein interaction involving the components of these signaling pathways. Even more, there has been strikingly evidence that, in some of these pathways, signal transduction occurs exclusively through protein-protein interaction, entirely dismissing any mediation by the signal molecule. In order to validate and evaluate the global relevance of this type of mechanism, this study proposed the investigation of the entire network of interactions between proteins typically associated with c-di-GMP signaling pathways of Pseudomonas aeruginosa by employing bacterial two-hybrid system assays. To make that possible, two DNA libraries were constructed and interaction essays were performed in a strategic way so that all possibilities of interaction between target proteins were explored. The results obtained from these experiments allowed the construction of a broad map of interactions that, although still primitive, indicates that, chances are, the mechanisms previously described are both recurrent and relevant to signaling regulation in this organism. Some of the interaction partners found are particularly interesting and will be further investigated in future studies.
Jones, Christine. "Guanosine 5'-diphosphate 3'-diphosphate (ppGpp), guanosine 5'-diphosphate 3'-monophosphate (ppGp) and antibiotic production in Streptomyces clavuligerus". Thesis, University of Central Lancashire, 1996. http://clok.uclan.ac.uk/19767/.
Texto completoBastani, A. "Biochemical study of cytidine 3',5' cyclic monophosphate phosphodiesterase activity". Thesis, Swansea University, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.636051.
Texto completoVarandani, Anjali. "Adenosine 3', 5'-cyclic monophosphate activation of islet chloride channels". VCU Scholars Compass, 1998. https://scholarscompass.vcu.edu/etd/5621.
Texto completoHakeem, N.-A. S. "Biochemical studies of cytidine 3', 5'-cyclic monophosphate and other novel endogenous cyclic nucleotides". Thesis, Swansea University, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.539786.
Texto completoHidir, Saadiah M. "The inhibitory effect of cyclic 3',5' adenosine monophosphate and putrescine in inflammation". Thesis, Aston University, 1985. http://publications.aston.ac.uk/12501/.
Texto completoAmini, Fahim. "The role of 3',5'-cyclic adenosine monophosphate (cAMP) in Streptomyces coelicolor A3(2)". Thesis, University of Warwick, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.484191.
Texto completoLibros sobre el tema "Cyclic guanosine 3',5'-monophosphate"
Hidir, Saadiah Mohd. The inhibitory effect of cyclic 3',5' adenosine monophosphate and putrescine in inflammation. Birmingham: University of Aston. Department of Pharmacy, 1985.
Buscar texto completoAmini, Fahim. The role of 3',5'-cyclic adenosine monophosphate (cAMP) in Streptomyces coelicolor A3(2). 1994.
Buscar texto completoCapítulos de libros sobre el tema "Cyclic guanosine 3',5'-monophosphate"
Goldberg, Nelson D. y Ann G. O'Toole. "Analysis of Cyclic 3′,5′-Adenosine Monophosphate and Cyclic 3′,5′-Guanosine Monophosphate". En Methods of Biochemical Analysis, 1–39. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2006. http://dx.doi.org/10.1002/9780470110393.ch1.
Texto completoBartsch, W., K. Strein, E. Böhm, G. Sponer y B. Müller-Beckmann. "Isosorbide-5-Mononitrate Increases Cyclic Guanosine Monophosphate Concentration in Rat Aorta in Vitro and in Vivo". En Mononitrates, 34–38. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70234-1_6.
Texto completoLockette, Warren, Yuji Otsuka y Elizabeth Hirt. "The Endothelium and Cyclic Guanosine Monophosphate in Hyperthyroid-Induced Hypertension". En Vasodepressor Hormones in Hypertension: Prostaglandins and Kallikrein-Kinins, 125–32. Basel: Birkhäuser Basel, 1987. http://dx.doi.org/10.1007/978-3-0348-9299-5_13.
Texto completoHeinemann, L., P. T. Sawicki, G. Stroka, C. Angenvoort, A. Hohmann y M. Berger. "Cyclic Guanosine Monophosphate Concentrations in Type 1 Diabetic Patients in Different Stages of Diabetic Nephropathy". En Endocrinology of the Heart, 195–97. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83858-3_34.
Texto completoPerez, Dominique, Peter C. Simons, Yelena Smagley, Larry A. Sklar y Alexandre Chigaev. "A High-Throughput Flow Cytometry Assay for Identification of Inhibitors of 3′,5′-Cyclic Adenosine Monophosphate Efflux". En Methods in Molecular Biology, 227–44. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3673-1_15.
Texto completoSasaki, Fumiaki, Sandra L. Schneider y Paul M. Zeltzer. "Dibutyryl adenosine 3′:5′-cyclic monophosphate (db-cAMP) induced growth inhibition and morphologic changes in human medulloblastoma cell line TE671". En Biology of Brain Tumour, 27–34. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4613-2297-9_4.
Texto completoScoble, J. E., D. Moskowitz y K. A. Hruska. "Dibutryladenosine 3’, 5’-Cyclic Monophosphate (dBcAMP) does not Mimic the Action of Parathyroid Hormone (PTH) on Canine Proximal Tubular Basolateral Membrane Na+:Ca2+". En Phosphate and Mineral Homeostasis, 537–41. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-5206-8_67.
Texto completoSAWYER, C., A. HONDA y W. DOSTMANN. "CygnetsIntracellular Guanosine 3′,5′-Cyclic Monophosphate Sensing in Primary Cells Using Fluorescence Energy Transfer". En Cell Biology, 299–306. Elsevier, 2006. http://dx.doi.org/10.1016/b978-012164730-8/50111-8.
Texto completo"Adenosine 3′, 5′ Cyclic Monophosphate (cAMP)". En Encyclopedia of Genetics, Genomics, Proteomics and Informatics, 34. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6754-9_264.
Texto completoZakaria, Zainul Amiruddin. "Clinacanthus nutans L., analgesia, and the l-arginine/nitric oxide-mediated/cyclic-guanosine monophosphate-independent pathway". En The Neurobiology, Physiology, and Psychology of Pain, 103–15. Elsevier, 2022. http://dx.doi.org/10.1016/b978-0-12-820589-1.00010-5.
Texto completoActas de conferencias sobre el tema "Cyclic guanosine 3',5'-monophosphate"
Deweever, A., S. Subedi Paudel, C. Zhou, K. Battle, R. Balczon, D. T. Tambe y T. Stevens. "Exoenzyme Y - Generated Uridine - 3', 5'- Cyclic Monophosphate Contributes to Pulmonary Edema During Pseudomonas Aeruginosa Infection". En American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1227.
Texto completoFu, Bingmei M. y Bin Chen. "A Model for the Structural Mechanisms in the Regulation of Microvessel Permeability by cAMP". En ASME 2001 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2001. http://dx.doi.org/10.1115/imece2001/htd-24416.
Texto completoPedvis, L. G., T. Wong, J. Wylie y M. M. Frojmovic. "DIFFERENTIAL INHIBITION OF THE PLATELET ACTIVATION SEQUENCE: SHAPE CHANGE, MICRO- AND MACRO- AGGREGATION, BY A STABLE PROSTACYCLIN ANALOGUE (IL0PR0ST)". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643451.
Texto completo